Dusseldorf - Delayed Quote • EUR DaVita Inc (TRL.DU) Follow Compare 161.60 +0.65 +(0.40%) As of 8:10:47 AM GMT+1. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider DaVita HealthCare (DVA) closed at $169.90 in the latest trading session, marking a +0.86% move from the prior day. Masimo Stock Gains Following Solid Preliminary Q4 Revenues MASI's revenue growth in the fourth quarter is likely to have been boosted by the continued robust adoption of its products. Is DaVita (DVA) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. DaVita HealthCare (DVA) Gains But Lags Market: What You Should Know DaVita HealthCare (DVA) concluded the recent trading session at $166.24, signifying a +0.84% move from its prior day's close. Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article. Is DaVita Inc. (DVA) the Cheap Value Stock to Invest in According to Warren Buffett? We recently published a list of 10 Cheap Value Stocks to Invest in According to Warren Buffett. In this article, we are going to take a look at where DaVita Inc. (NYSE:DVA) stands against other cheap value stocks to invest in according to Warren Buffett. Has Warren Buffett given up on stocks amid overstretched valuations? That’s the […] 4 Stocks to Monitor in a Dynamic Outpatient Home Health Industry An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, OPCH and ADUS are well-poised to gain. DaVita HealthCare (DVA) Ascends But Remains Behind Market: Some Facts to Note The latest trading day saw DaVita HealthCare (DVA) settling at $162.36, representing a +0.22% change from its previous close. DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health DaVita, a comprehensive kidney care provider, is celebrating 25 years of clinical care delivery and leadership in healthcare innovation. Since forming with a purpose "to give life" in 2000, DaVita has focused its efforts to improve clinical outcomes, enhance quality of life for patients and be a force for positive change for the healthcare system. By fostering an inclusive, mission-driven workforce and building strong community partnerships, DaVita is helping empower the future of kidney health. DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires DaVita, a comprehensive kidney care provider, has activated its emergency response plan as devastating wildfires spread across Southern California. DaVita's emergency response plan includes: DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts DaVita HealthCare (DVA) closed the most recent trading day at $152.69, moving +0.77% from the previous trading session. DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts The latest trading day saw DaVita HealthCare (DVA) settling at $151.53, representing a -0.84% change from its previous close. Compelling Reasons for Investors to Hold on to Centene Stock CNC remains well-poised for growth on the back of an expanding customer base, improved premiums, strategic acquisitions and commendable cash reserves. Should Value Investors Buy DaVita (DVA) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. DaVita HealthCare (DVA) Stock Moves -0.16%: What You Should Know DaVita HealthCare (DVA) closed at $149.55 in the latest trading session, marking a -0.16% move from the prior day. DaVita Inc. (DVA): Among the Cheap Healthcare Stocks to Buy Heading Into 2025 We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this article, we are going to take a look at where DaVita Inc. (NYSE:DVA) stands against the other cheap healthcare stocks. The Resilience and Challenges of Global Healthcare Spending Investing in healthcare equities is typically seen as protective during […] DaVita HealthCare (DVA) Laps the Stock Market: Here's Why In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $155.06, denoting a +1.33% change from the preceding trading day. The Best Warren Buffett Stocks to Buy With $250 Right Now Warren Buffett is recognized for his legendary ability to uncover high-quality and undervalued companies to invest in. Under his leadership, Berkshire Hathaway (NYSE: BRK.B) (NYSE: BRK.A) has crushed the returns of stock market benchmarks like the S&P 500 index. For retail investors, the conglomerate's massive stock portfolio can be a great place to start looking for investing ideas. DaVita Stock Sees Improved Relative Strength Rating A Relative Strength Rating upgrade for DaVita shows improving technical performance. Will it continue? DaVita Stock Gains 40.1% Year to Date: What's Behind the Rally? Strength in kidney care services and expansion into international markets raise optimism for DVA stock. Performance Overview Trailing total returns as of 1/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return TRL.DU S&P 500 YTD +10.31% +3.13% 1-Year +69.43% +25.23% 3-Year +66.46% +38.52%